eIF4F控制了黑色素瘤中具有BRAF和NRAS突变的ERK MAPK信号
Barbora Valcikova1,2, Natalia Vadovicova1,2, Karolina Smolkova1,2
1Department of Biology, Faculty of Medicine, Masaryk University, Brno 62500, Czech Republic.
概括
eIF4F复合体在黑色素瘤中负面调节MAPK通路. 抑制eIF4F会破坏这种反,导致ERK过度激活,这对于了解黑色素瘤的治疗耐药性至关重要.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 信号传输 信号传输
背景情况:
- eIF4F翻译启动复合体与黑色素瘤的耐药性有关.
- 基因激活蛋白激酶 (MAPK) 途径,包括RAS/RAF/MEK/ERK,在黑色素瘤中经常失调.
研究的目的:
- 研究eIF4F在调节黑色素瘤中MAPK信号通路中的作用.
- 了解eIF4F如何影响BRAF或NRAS突变的黑色素瘤细胞中的ERK信号强度和反机制.
主要方法:
- 研究了eIF4F在RAS/RAF/MEK/ERK MAPK通路的负调节中的功能.
- 评估了eIF4F在控制黑色素瘤细胞中ERK信号强度方面的作用.
- 使用了小分子eIF4F抑制剂以及体外和体外的定量分析.
主要成果:
- eIF4F对于控制BRAF或NRAS突变的未经治疗的黑色素瘤细胞中的ERK信号强度至关重要.
- DUSP6/MKP3是ERK的负反调节器,需要依赖eIF4F的生产来限制过度的ERK信号.
- 抑制eIF4F会破坏MAPK的负反,导致ERK过度活化和EGR1过度表达.
结论:
- eIF4F在黑色素瘤中对MAPK信号流的负调节中起着至关重要的作用.
- 依赖eIF4F的反机制对于维持ERK正常活动至关重要.
- 药理上的eIF4F抑制可以通过激活BRAF和NRAS突变来破坏黑色素瘤中的MAPK负反.
相关概念视频
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


